|
Volumn 9, Issue 4, 2001, Pages 355-362
|
Influence of antidepressant pharmacotherapy on behavioral treatment adherence and smoking cessation outcome in a combined treatment involving fluoxetine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDEPRESSANT AGENT;
COTININE;
FLUOXETINE;
NICOTINE;
NORFLUOXETINE;
ADOLESCENT;
ADULT;
ARTICLE;
BEHAVIOR THERAPY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG DEPENDENCE TREATMENT;
DRUG EFFECT;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PATIENT COMPLIANCE;
PREDICTION;
PSYCHOPHARMACOTHERAPY;
RANDOMIZED CONTROLLED TRIAL;
SINGLE BLIND PROCEDURE;
SMOKING;
SMOKING CESSATION;
ADULT;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
BEHAVIOR THERAPY;
COMBINED MODALITY THERAPY;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
FEMALE;
FLUOXETINE;
HUMANS;
MALE;
MIDDLE AGED;
PROGNOSIS;
SEX FACTORS;
SMOKING CESSATION;
TREATMENT OUTCOME;
|
EID: 0035210281
PISSN: 10641297
EISSN: None
Source Type: Journal
DOI: 10.1037/1064-1297.9.4.355 Document Type: Article |
Times cited : (21)
|
References (23)
|